SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+7.54%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$201M
AUM Growth
+$201M
(-11%)
Cap. Flow
-$33.7M
Cap. Flow
% of AUM
-16.75%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
72
New
14
Increased
15
Reduced
25
Closed
16
Top Buys
| 1 |
Stryker
SYK
|
$5.99M |
| 2 |
Merck
MRK
|
$5.19M |
| 3 |
Johnson & Johnson
JNJ
|
$4.85M |
| 4 |
GSK
GSK
|
$4.33M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$4.17M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$8.47M |
| 2 |
McKesson
MCK
|
$8.02M |
| 3 |
AET
Aetna Inc
AET
|
$7.94M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$5.9M |
| 5 |
Abbott
ABT
|
$5.23M |
Sector Composition
| 1 | Healthcare | 89.51% |
| 2 | Energy | 1.94% |
| 3 | Financials | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$21B
| $7.22M | 3.59% | 60,000 +10,000 | +20% | +$1.2M |
|
2
Boston Scientific
BSX
$156B
| $7.01M | 3.49% | 300,000 | – | – |
|
3
Centene
CNC
$14.3B
| $6.52M | 3.24% | 91,300 -8,700 | -9% | -$621K |
|
4
Universal Health Services
UHS
$11.6B
| $6.04M | 3% | 45,000 -30,000 | -40% | -$4.02M |
|
|
5
Stryker
SYK
$150B
| $5.99M | 2.98% | +50,000 | New | +$5.99M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $5.59M | 2.78% | 65,000 +45,000 | +225% | +$3.87M |
|
7
HCA Healthcare
HCA
$94.5B
| $5.46M | 2.71% | 70,900 -54,100 | -43% | -$4.17M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $5.43M | 2.7% | 55,000 +15,000 | +38% | +$1.48M |
|
9
Amgen
AMGN
$155B
| $5.33M | 2.65% | 35,000 +20,000 | +133% | +$3.04M |
|
10
Medtronic
MDT
$119B
| $5.21M | 2.59% | 60,000 +15,000 | +33% | +$1.3M |
|
|
11
Merck
MRK
$210B
| $5.19M | 2.58% | +90,000 | New | +$5.19M |
|
|
12
Johnson & Johnson
JNJ
$427B
| $4.85M | 2.41% | +40,000 | New | +$4.85M |
|
13
Tenet Healthcare
THC
$16.3B
| $4.84M | 2.4% | 175,000 +15,000 | +9% | +$415K |
|
14
Biogen
BIIB
$19.4B
| $4.84M | 2.4% | 20,000 +5,000 | +33% | +$1.21M |
|
|
SHPG
15
DELISTED
Shire pic
SHPG
| $4.6M | 2.29% | 25,000 +5,000 | +25% | +$920K |
|
16
Agilent Technologies
A
$35.7B
| $4.44M | 2.21% | 100,076 +5,076 | +5% | +$225K |
|
17
Thermo Fisher Scientific
TMO
$186B
| $4.43M | 2.2% | 30,000 | – | – |
|
|
18
GSK
GSK
$79.9B
| $4.33M | 2.15% | +100,000 | New | +$4.33M |
|
|
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
| $4.17M | 2.07% | +55,000 | New | +$4.17M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $4.05M | 2.01% | 55,000 -25,000 | -31% | -$1.84M |
|
21
Eli Lilly
LLY
$657B
| $3.94M | 1.96% | +50,000 | New | +$3.94M |
|
22
Labcorp
LH
$23.1B
| $3.91M | 1.94% | +30,000 | New | +$3.91M |
|
|
LHCG
23
DELISTED
LHC Group LLC
LHCG
| $3.9M | 1.94% | 90,000 -20,000 | -18% | -$866K |
|
|
AET
24
DELISTED
Aetna Inc
AET
| $3.66M | 1.82% | 30,000 -65,000 | -68% | -$7.94M |
|
25
Quest Diagnostics
DGX
$20.3B
| $3.66M | 1.82% | +45,000 | New | +$3.66M |
|